This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration

09 MAY
2024

A baby girl born deaf can hear unaided for the first time, after receiving gene therapy when she was 11 months old at Addenbrooke’s Hospital in Cambridge.

Opal Sandy from Oxfordshire is the first patient treated in a global gene therapy trial, which shows 'mind-blowing' results. She is the first British patient in the world and the youngest child to receive this type of treatment. Opal was born completelReadmore

May 16
2024

New gene delivery vehicle shows promise for human brain gene therapy

In an important step toward more effective gene therapies for brain diseases, researchers from the Broad Institute of MIT and Harvard have engineered a gene-delivery vehicle that uses a human protein to efficiently cross the blood-brain barrier and deliveReadmore

May 21
2024

Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation

CAMBRIDGE, Mass., May 21, 2024 /PRNewswire/ Nanopath Inc a point-of-care diagnostics company enabling high-quality molecular testing in minutes, announced today that it was awarded $4 million in federal funding. The company was awarded a $3 million grant Readmore

23 May
2024

En Carta Diagnostics secures €1.5M for rapid Lyme disease diagnostic kits

En Carta’s technology is a rapid Point-of-Care diagnostic platform, in a frugal cassette format.Readmore

22 MAR
2024

Messenger RNAs with multiple “tails” could lead to more effective therapeutics Scientists have engineered long lasting mRNAs that increased therapeutic protein production in cells and animals.

Researchers from the Broad Institute of MIT and Harvard and MIT have engineered a new mRNA structure by adding multiple “tails” to the molecules that boosted mRNA activity levels in cells by 5 to 20 times.Readmore

16 FEB
2024

Cambridge scientists have identified more than one hundred key genes linked to DNA damage through systematic screening of nearly 1,000 genetically modified mouse lines. The work, published in Nature, provides insights into cancer progression and neurodege

The genome contains all the genes and genetic material within an organism's cells. When the genome is stable, cells can accurately replicate and divide, passing on correct genetic information to the next generation of cells. Despite its significance, littReadmore

02 JAN
2024

A previously unidentified genetic mutation in a small protein provides significant protection against Parkinson’s disease and offers a new direction for exploring potential treatments, according to a new USC Leonard Davis School of Gerontology study.

A previously unidentified genetic mutation in a small protein provides significant protection against Parkinson’s disease and offers a new direction for exploring potential treatments, according to a new USC Leonard Davis School of Gerontology study.Readmore

5 SEP
2023

Your gene Health launches Mag Bench Automated DNA Extraction Instrument and Kit for NIPT workflows

DNA Extraction Instrument and Kit. Mag Bench solution is available to Sage™ customers across Asia-Pacific and the Middle East. Mag Bench offers a simple, fast, and cost-efficient, bench-top robotic cell-free DNAReadmore

24 AUG
2023

Genetics and environment influence immune responses to SARS-CoV-2

COVID-19 pandemic, the clinical spectrum observed among people infected with SARS-CoV-2 ranged from asymptomatic carriage to death. Researchers at the Institut Pasteur, the CNRS and the Collège de France, in collaboration with researchers around the worReadmore

14 AUG
2023

New diagnostic tool could revolutionize early bladder cancer detection

Molecular Diagnostics, published by Elsevier, investigators report on a promising new diagnostic tool that may pave the way for an important breakthrough in early diagnosis of bladder cancer in patients with blood in their urine (hematuria), reducing the Readmore

5 AUG
2023

Molecular QC and EQA for Infectious Disease Testing

Earlier this year, randox entered into a strategic partnership, bringing on-board qnostics Molecular Controls and QCMD Molecular EQA which comprises hundreds of controls and EQA programmes for molecular infectious disease testing. Readmore

4 AUG
2023

How can AI oncology diagnostics help the NHS?

Deep Med has developed an AI oncology diagnostics system, Deep Path TM – LYDIA, to assist histopathologists in performing lymph node metastasis detection quickly and accuratelyReadmore

19 JULY
2023

New refget version improves reliability of genomic data analysis

A widely-used tool that finds the exact references needed to pinpoint differences in our DNA just got a refresh Readmore

3 APR
2023

The potential of microparticles for active surveillance of infectious diseases

Emmanuel Ki faro from the SACIDS Foundation for One Health, and College of Veterinary Medicine and Biomedical Sciences, Sokoine University of Agriculture, Tanzania, details the potential application of microparticles for active surveillance of viral infecReadmore

31 MAR
2023

Owkin launches PortrAIt – a €33 million project to make France a global leader in using AI to diagnose and treat diseases

France is set to become a global leader in artificial intelligence-powered precision medicine through a new €33 million Bpifrance-funded consortium project led by French AI biotech company Owkin.Readmore

15 MAR
2023

Cepheid Receives Health Canada Licence for Xpert® Xpress CoV-2 plus

Health Canada has issued Cepheid a medical device licence for Xpert® Xpress CoV-2plus, a rapid molecular diagnostic test for qualitative detection of the virus that causes COVID-19. Readmore

8 MAR
2023

Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine Providing a comprehensive digital diagnostic pathology system for enhanced clinical utility

Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutioReadmore

21 FEB
2023

International collaboration awarded $US8 million to design world-first diagnostic tool for acute rheumatic fever

Researchers from Telethon Kids Institute are joining forces with international experts in acute rheumatic fever (ARF) and rheumatic heart disease (RHD) to transform the diagnosis of these diseases thanks to an $US8 million grant from the Leducq FoundationReadmore

14 FEB
2023

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox First Point-of-Care Test for Mpox

Cepheid announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for Xpert MpoxReadmore

8 FEB
2023

BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination Test

Single Test on BD MAX™ Molecular Diagnostic System Identifies and Differentiates Multiple Respiratory Infectious DiseasesReadmore

02 FEB
2023

National Diagnostics Catapult, C-CAMP InDx 2.0 Launched

The Centre for Cellular and Molecular Platforms (C-CAMP) has launched the National Diagnostics Catapult (C-CAMP InDx 2.0) in New Delhi on February 2nd, 2023 in presence of Dr Parvinder Maini, Office of the Principal Scientific Adviser (PSA) to the GovernReadmore

01 FEB
2023

White & Case Advises Biosynex on Merger Agreement With Chembio Diagnostics, Inc.

Global law firm White & Case LLP has advised Biosynex SA, a market-leading designer and distributor of rapid diagnostic tests, on its entry into a definitive merger agreement with Chembio Diagnostics, Inc.Readmore

25 JAN
2023

Rapid tests make diagnosis of Hepatitis C more accessible and closer to the community, study finds

A new study has shown the benefit of using a quick clinic-based diagnostic test for hepatitis C virus (HCV) infection over a standard laboratory-based test. Readmore

20 JAN
2023

International research team determines best first line of defense against common arrhythmia

An international team of researchers from across Canada and in Germany have discovered cryoablation, which scars the heart’s tissue with the goal of interrupting the faulty electrical signals that cause the conditionReadmore

17 JAN
2023

Major grant awarded to tackle antibiotic resistance

Vital research aiming to improve the treatment of potentially deadly Group A Streptococcus (Strep A) has been awarded $820,000 in the latest round of National Health and Medicine Research Council’s Ideas Grants. Readmore

10 JAN
2023

Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment

Argonaut Manufacturing Services announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities. Readmore

06 JAN
2023

University of Tartu received €30 million to develop a centre of excellence for personalised medicine

Over the next six years, a consortium led by the University of Tartu and Tartu University Hospital will establish a personalised medicine research and development centre of international excellence in Estonia. The project is supported by the European CommReadmore

Subscribe to our News & Updates